Proacta S.A. (WSE:PAC)

Poland · Delayed Price · Currency is PLN

1.630

-0.020 (-1.21%)

At close: Jun 15, 2026

42.98% (1Y)

Market Cap	191.40M +66.3%
Revenue (ttm)	12.51M +164.8%
Net Income	2.96M
EPS	0.03
Shares Out	117.43M
PE Ratio	64.71
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,622
Open	1.580
Previous Close	1.650
Day's Range	1.560 - 1.660
52-Week Range	0.660 - 2.720
Beta	1.09
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Proacta

Proacta S.A. develops and provides IT solutions. The company specializes in artificial intelligence, bioinformatics, and advanced medical and genetic data analysis. The company offers Dbam o siebie Smart LAB, a platform that generates personalized reports based on laboratory test results; DBCU, an innovative platform using advanced technologies to optimize the breast cancer treatment process; and Patient Portal, an innovative tool for monitoring health, managing medical data, and supporting the treatment process. It also provides AI/ML services... [Read more]

Industry Computer Programming, Data Processing, And Other Computer Related Services

Founded 2015

Employees 16

Stock Exchange Warsaw Stock Exchange

Ticker Symbol PAC

Full Company Profile

Financial Performance

In 2024, Proacta's revenue was 3.12 million, an increase of 380.99% compared to the previous year's 647,669. Losses were -9.54 million, 862.8% more than in 2023.

Financial Statements